Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Oct 15;210(8):971-973.
doi: 10.1164/rccm.202407-1496ED.

Paradigm Shift in ICU Candidacy for Allogeneic Hematopoietic Stem Cell Transplantation: Who, When, and How Long?

Marina García-de-Acilu  1   2 , Laveena Munshi  3   4 , Oriol Roca  1   2   5
Affiliations
Editorial

Paradigm Shift in ICU Candidacy for Allogeneic Hematopoietic Stem Cell Transplantation: Who, When, and How Long?

Marina García-de-Acilu et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Clinical decision-making processes in critically ill patients receiving allo-HSCT. aGVHD = acute graft-versus-host disease; allo-HSCT = allogeneic hematopoietic stem-cell transplantation; TMA = thrombotic microangiopathy; VOD = venoocclusive disease.
See this image and copyright information in PMC

Comment on

  • Outcomes in Critically Ill Allogeneic Hematopoietic Stem-Cell Transplantation Recipients.
    Lafarge A, Dupont T, Canet E, Moreau AS, Picard M, Mokart D, Platon L, Mayaux J, Wallet F, Issa N, Raphalen JH, Pène F, Renault A, Peffault de la Tour R, Récher C, Chevallier P, Zafrani L, Darmon M, Bigé N, Azoulay E. Lafarge A, et al. Am J Respir Crit Care Med. 2024 Oct 15;210(8):1017-1024. doi: 10.1164/rccm.202401-0135OC. Am J Respir Crit Care Med. 2024. PMID: 39018219

References

    1. Gratwohl A, Pasquini MC, Aljurf M, Atsuta Y, Baldomero H, Foeken L, et al. Worldwide Network for Blood and Marrow Transplantation (WBMT) One million haemopoietic stem-cell transplants: a retrospective observational study. Lancet Haematol . 2015;2:e91–100. - PubMed
    1. Pène F, Aubron C, Azoulay E, Blot F, Thiéry G, Raynard B, et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol . 2006;24:643–649. - PubMed
    1. Munshi L, Dumas G, Rochwerg B, Shoukat F, Detsky M, Fergusson DA, et al. Long-term survival and functional outcomes of critically ill patients with hematologic malignancies: a Canadian multicenter prospective study. Intensive Care Med . 2024;50:561–572. - PubMed
    1. Lafarge A, Dupont T, Canet E, Moreau AS, Picard M, Mokart D, et al. Outcomes in critically ill allogeneic hematopoietic stem-cell transplantation recipients. Am J Respir Crit Care Med . 2024;210:1017–1024. - PubMed
    1. Jamy O, Dasher J, Chen A, Salzman D, Bhatia R, Bhatia S. Impact of pre-transplant individual comorbidities on risk of ICU admission and survival outcomes following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant . 2023;58:311–316. - PubMed

LinkOut - more resources